{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T12:54:51Z","timestamp":1695473691041},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.beha.2010.06.001","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T09:18:10Z","timestamp":1284628690000},"page":"231-236","source":"Crossref","is-referenced-by-count":1,"title":["Non-myeloablative umbilical cord blood transplantation"],"prefix":"10.1016","volume":"23","author":[{"given":"Mitchell E.","family":"Horwitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.beha.2010.06.001_bib1","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy","volume":"89","author":"Giralt","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2010.06.001_bib2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2010.06.001_bib3","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","article-title":"Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects","volume":"97","author":"McSweeney","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2010.06.001_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"27","key":"10.1016\/j.beha.2010.06.001_bib5","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1200\/JCO.2006.09.7865","article-title":"Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation","volume":"25","author":"Sorror","year":"2007","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.beha.2010.06.001_bib6","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1200\/JCO.2008.20.9692","article-title":"Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia","volume":"27","author":"Ringden","year":"2009","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.beha.2010.06.001_bib7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/blood.V112.11.348.348","article-title":"Similar outcomes using myeloablative versus reduced intensity and non-myeloablative allogeneic transplant preparative regimens for AML or MDS: from the Center for International Blood and Marrow Transplant Research","volume":"112","author":"Luger","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2010.06.001_bib8","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1182\/blood.V98.12.3486","article-title":"Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen","volume":"98","author":"Rizzieri","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2010.06.001_bib9","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood.V97.10.2957","article-title":"Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis","volume":"97","author":"Barker","year":"2001","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2010.06.001_bib10","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2007-04-067215","article-title":"Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease","volume":"110","author":"Brunstein","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2010.06.001_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00277-006-0190-5","article-title":"Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan","volume":"86","author":"Komatsu","year":"2007","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.beha.2010.06.001_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbmt.2008.02.016","article-title":"Myeloablative intravenous busulfan\/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients","volume":"14","author":"Horwitz","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl. 1","key":"10.1016\/j.beha.2010.06.001_bib13","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/01.cco.0000357473.58411.1b","article-title":"Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies","volume":"21","author":"Rocha","year":"2009","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"10.1016\/j.beha.2010.06.001_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bbmt.2008.03.003","article-title":"Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases","volume":"14","author":"Uchida","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.beha.2010.06.001_bib15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1182\/blood-2009-01-196303","article-title":"Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313","volume":"114","author":"Pulsipher","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2010.06.001_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbmt.2005.01.012","article-title":"Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma","volume":"11","author":"Yuji","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.beha.2010.06.001_bib17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbmt.2008.11.013","article-title":"Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation","volume":"15","author":"Brunstein","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.beha.2010.06.001_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2007.15.8865","article-title":"Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation","volume":"27","author":"Rodrigues","year":"2009","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.beha.2010.06.001_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbmt.2005.04.005","article-title":"Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma","volume":"11","author":"Dean","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.beha.2010.06.001_bib20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood-2003-05-1406","article-title":"BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients","volume":"103","author":"Faulkner","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2010.06.001_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3324\/haematol.10924","article-title":"Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)","volume":"92","author":"Vigouroux","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.beha.2010.06.001_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.TP.0000163289.20406.86","article-title":"Early immune reaction after reduced-intensity cord-blood transplantation for adult patients","volume":"80","author":"Kishi","year":"2005","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.beha.2010.06.001_bib23","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1158\/1078-0432.CCR-03-0754","article-title":"Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases","volume":"10","author":"Miyakoshi","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.beha.2010.06.001_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbmt.2006.08.041","article-title":"Double unrelated reduced-intensity umbilical cord blood transplantation in adults","volume":"13","author":"Ballen","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.beha.2010.06.001_bib25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bbmt.2004.05.001","article-title":"Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens","volume":"10","author":"Chao","year":"2004","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692610000319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692610000319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T20:24:35Z","timestamp":1591907075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692610000319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1521692610000319"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2010.06.001","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}